• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载精氨酸的金属有机框架纳米颗粒增敏骨肉瘤放射治疗。

D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy.

机构信息

Department of Orthopedics, Peking University Third Hospital, Beijing, 100191, PR China.

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS), Beijing, 100049, PR China.

出版信息

Biomaterials. 2021 Feb;269:120642. doi: 10.1016/j.biomaterials.2020.120642. Epub 2021 Jan 2.

DOI:10.1016/j.biomaterials.2020.120642
PMID:33440291
Abstract

Osteosarcoma is a common type of bone cancers with a high rate of pulmonary recurrence. High-dose radiation therapy is useful for the ablation of unresectable osteosarcoma. However, it may cause severe adverse effects. To address this problem, we developed D-arginine-loaded metal-organic frameworks (MOF) nanoparticles for improving the radiosensitivity of osteosarcoma. D-arginine, a metabolically inert enantiomer of L-arginine, could produce nitric oxide and down-regulate hypoxia-inducible factor-1alpha (HIF-1α) to alleviate tumor hypoxia. In addition, MOF could also generate free radicals to kill the tumor cells. Results demonstrate that D-arginine-loaded nanoparticles enhanced tumor ablation and prevented the lung metastasis in mice upon radiation therapy. Furthermore, the nanoparticles or radiation alone had relatively low toxicity in cells and mice. Therefore, D-arginine-loaded MOF nanoparticles are relatively safe and highly effective in sensitizing osteosarcoma to radiotherapy.

摘要

骨肉瘤是一种常见的骨癌,其肺部复发率较高。高剂量辐射治疗对不可切除的骨肉瘤消融有效。然而,它可能会引起严重的不良反应。为了解决这个问题,我们开发了负载 D-精氨酸的金属有机骨架(MOF)纳米颗粒,以提高骨肉瘤的放射敏感性。D-精氨酸是 L-精氨酸的代谢惰性对映体,可产生一氧化氮并下调缺氧诱导因子-1α(HIF-1α),从而减轻肿瘤缺氧。此外,MOF 还可以产生自由基杀死肿瘤细胞。结果表明,负载 D-精氨酸的纳米颗粒增强了肿瘤消融,并在放射治疗后预防了小鼠的肺转移。此外,纳米颗粒或单独的辐射在细胞和小鼠中具有相对较低的毒性。因此,负载 D-精氨酸的 MOF 纳米颗粒在提高骨肉瘤放射敏感性方面具有相对安全性和高效性。

相似文献

1
D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy.载精氨酸的金属有机框架纳米颗粒增敏骨肉瘤放射治疗。
Biomaterials. 2021 Feb;269:120642. doi: 10.1016/j.biomaterials.2020.120642. Epub 2021 Jan 2.
2
Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.载全氟正丁基三胺/替拉扎明的聚多巴胺包覆的 UiO-66 纳米粒子用于缺氧激活骨肉瘤治疗。
J Nanobiotechnology. 2021 Sep 30;19(1):298. doi: 10.1186/s12951-021-01013-0.
3
Polydopamine-cloaked Fe-based metal organic frameworks enable synergistic multidimensional treatment of osteosarcoma.聚多巴胺包覆的铁基金属有机框架实现骨肉瘤的协同多维治疗。
J Colloid Interface Sci. 2023 Dec;651:76-92. doi: 10.1016/j.jcis.2023.07.146. Epub 2023 Jul 25.
4
Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.负载阿霉素的叶酸修饰金属有机框架用于骨肉瘤的肿瘤靶向化疗
Biomed Tech (Berl). 2020 Apr 28;65(2):229-236. doi: 10.1515/bmt-2019-0056.
5
Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.缺氧诱导因子-1α的抑制在体外使MG-63人骨肉瘤细胞对辐射敏感。
Tumori. 2015 Sep-Oct;101(5):578-84. doi: 10.5301/tj.5000243. Epub 2015 Aug 4.
6
Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.基于金属有机框架纳米粒子的光动力治疗联合抗低氧信号和 CpG 佐剂的原位肿瘤疫苗增强癌症免疫治疗。
Adv Healthc Mater. 2020 Jan;9(1):e1900996. doi: 10.1002/adhm.201900996. Epub 2019 Nov 20.
7
Tantalum-Zirconium Co-Doped Metal-Organic Frameworks Sequentially Sensitize Radio-Radiodynamic-Immunotherapy for Metastatic Osteosarcoma.钽锆共掺杂金属有机框架材料序贯敏感放化疗免疫治疗转移性骨肉瘤。
Adv Sci (Weinh). 2023 Apr;10(10):e2206779. doi: 10.1002/advs.202206779. Epub 2023 Feb 5.
8
The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.HIF-1α/CXCR4通路支持缺氧诱导的人骨肉瘤细胞转移。
Cancer Lett. 2015 Feb 1;357(1):254-264. doi: 10.1016/j.canlet.2014.11.034. Epub 2014 Nov 18.
9
HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.HIF-1α 介导的自噬决定了 ZnO 纳米颗粒在体内外诱导人骨肉瘤细胞死亡。
ACS Appl Mater Interfaces. 2020 Oct 28;12(43):48296-48309. doi: 10.1021/acsami.0c12139. Epub 2020 Oct 15.
10
DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.DEC2表达与HIF-1激活及人骨肉瘤的侵袭性呈正相关。
J Exp Clin Cancer Res. 2015 Feb 28;34(1):22. doi: 10.1186/s13046-015-0135-8.

引用本文的文献

1
Nanoscale metal-organic frameworks as a versatile platform for synergistic combination tumor therapy.纳米级金属有机框架作为协同联合肿瘤治疗的通用平台。
J Nanobiotechnology. 2025 Sep 2;23(1):601. doi: 10.1186/s12951-025-03625-2.
2
Biomedical Applications of Functionalized Composites Based on Metal-Organic Frameworks in Bone Diseases.基于金属有机框架的功能化复合材料在骨疾病中的生物医学应用
Pharmaceutics. 2025 Jun 8;17(6):757. doi: 10.3390/pharmaceutics17060757.
3
Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment.
材料驱动的疗法:彻底改变骨肉瘤治疗的功能性纳米材料设计范例
J Funct Biomater. 2025 Jun 5;16(6):213. doi: 10.3390/jfb16060213.
4
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.非酒精性脂肪性肝病中的铁代谢:一个有前景的治疗靶点。
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
5
An analytical review of the therapeutic application of recent trends in MIL-based delivery systems in cancer therapy.基于金属有机骨架(MIL)的递送系统在癌症治疗中的最新趋势的治疗应用分析综述。
Mikrochim Acta. 2025 Jan 16;192(2):89. doi: 10.1007/s00604-024-06944-7.
6
Oxygen/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis.用于增强替莫唑胺介导的凋亡和坏死的氧/一氧化氮双释放纳米酶
Mol Pharm. 2025 Jan 6;22(1):168-180. doi: 10.1021/acs.molpharmaceut.4c00817. Epub 2024 Nov 21.
7
Exploring the frontiers: The potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration.探索前沿:生物活性支架在骨肉瘤治疗和骨再生中的潜力与挑战。
Mater Today Bio. 2024 Sep 29;29:101276. doi: 10.1016/j.mtbio.2024.101276. eCollection 2024 Dec.
8
Multiple applications of metal-organic frameworks (MOFs) in the treatment of orthopedic diseases.金属有机框架材料(MOFs)在骨科疾病治疗中的多种应用。
Front Bioeng Biotechnol. 2024 Sep 4;12:1448010. doi: 10.3389/fbioe.2024.1448010. eCollection 2024.
9
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
10
Microenvironment-triggered cascade metal-polyphenolic nanozyme for ROS/NO synergistic hyperglycemic wound healing.微环境触发级联金属-多酚纳米酶用于 ROS/NO 协同性高血糖创面愈合。
Redox Biol. 2024 Jul;73:103217. doi: 10.1016/j.redox.2024.103217. Epub 2024 May 28.